Institute of Nuclear Medicine

"Institute of Nuclear Medicine" Khimki, JSC "Medicine" ("IYAM," Khimki) - the largest center of nuclear medicine in Russia and one of the largest in Europe, is a structural unit of JSC "Medicine" (clinic of academician Roitberg).

The Institute uses advanced technologies in the diagnosis and treatment of patients with cancer. Investments in its creation amounted to 8 billion rubles. The area of the outpatient diagnostic complex is 23,000 m2. The building of the Institute of Nuclear Medicine Khimki has an autonomous energy supply system and is accredited to the authoritative international rating system for certification of green buildings Leadership in Energy & Environmental Design (LEED). As of February 2021, IYAM Khimki is the only Russian project in the field of medicine that has passed the LEED examination.

Structure

According to information as of February 2021, the Institute includes: separation of radionuclide and radiation diagnostics; radiotherapy department; radionuclide therapy unit; as well as a cyclotron-radiochemical complex for the production of its own radiopharmacological drugs, including on the basis of 68Ga, 11C, 18F in accordance with domestic and international standards of quality and safety, including GMP standards.

IYAM Khimki has the best diagnostic and therapeutic equipment available today, produced by leading world manufacturers.

Appointment

On the basis of the Institute, scientific work will be carried out, international clinical research will be carried out, the latest radiological technologies and advanced methods of diagnosis and treatment based on smart technologies of nuclear medicine will be introduced, an international competence center will be created with ongoing educational programs to promote best practices and integrated solutions.

History

2021

Admission of first patients

May 14, 2021 it became known that the "Institute of Nuclear Medicine" received the first patients.

The Institute will provide comprehensive assistance in all areas of diagnosis and treatment of oncological diseases, as well as the use of technologies for the detection and treatment of malignant tumors.

On May 12, three residents of the Moscow Region were diagnosed with PET/CT at the Institute of Nuclear Medicine, a division of Medicine JSC (clinic of Academician Roitberg). Medical care for the first patients of the Institute was provided under the federal compulsory medical insurance program.

Patients came to us with bowel, lung and breast diseases for PET/CT diagnosis. For the procedure, each of the patients took from 15 to 19 minutes (depending on weight). Studies were carried out on equipment with a high-quality calculation of the obtained data, which makes it possible to identify the smallest foci. The results of the research will be transmitted to treating doctors who will be able to start treating patients in the very near future. The ability to obtain the results of such important informative studies with detailed decoding increases a person's chances of choosing a treatment and the timing of its delivery. If desired, patients can undergo treatment at our Institute as part of the compulsory medical insurance program, "said Sergey Dorofeev, vice president of Medicine JSC.

PET/CT as of May 2021 is the most informative method of visual radiation diagnosis in oncology. It allows you to establish with high accuracy the presence of malignant formations at an asymptomatic stage, which cannot be detected using other equipment. The Institute has a high-performance PET/KT scanner equipped with iterative data reconstruction technologies of the latest generation.

{{quote 'The Institute of Nuclear Medicine will raise the level of high-tech assistance to a completely different level of quality and capabilities, "said Grigory Roitberg, President of Medicine JSC (Roitberg Clinic). - The latest developments of leading American and European equipment manufacturers, the introduction of artificial intelligence, innovative techniques, the use of advanced medical practices - all this will change the tactics of diagnosing and treating cancer in our country, including solving the problem of outflow of patients from Russia for treatment abroad. There is no longer such a need. }}

"Institute of Nuclear Medicine" is a full-cycle expert center for the diagnosis and treatment of cancer, a platform for international clinical research, a center of competence for conducting educational practices. This is an institution where the method of teranostics will be applied - a promising approach in medicine, aimed both at the diagnosis and at the point destruction of cancer cells at the same time.

Obtaining Commissioning Permit

The state corporation Rosatom issued Medicine JSC permission to commission the building "Institute" Nuclear Medicine in. The situated near Moscow Khimki building passed the international certification of "green buildings" LEED and confirmed its environmental friendliness and energy efficiency. As of February 2021, equipment is being installed at the Institute and in April 2021 IYAM will be able to receive its first patients. More. here